Ann: Positive results from AI-116 in vitro studies, page-18

FY General Info....interesting space

Advances in generative AI have taken the tech world by storm. Biotech investors are making a big bet that similar computational methods could revolutionize drug discovery.

On Tuesday, ARCH Venture Partners and Foresite Labs, an affiliate of Foresite Capital, announced that they incubated Xaira Therapeutics and funded the AI biotech with $1 billion. Other investors in the new company, which has been operating in stealth mode for about six months, include F-Prime, NEA, Sequoia Capital, Lux Capital, Lightspeed Venture Partners, Menlo Ventures, Two Sigma Ventures and SV Angel.

https://techcrunch.com/2024/04/24/x...-1b-says-its-ready-to-start-developing-drugs/

https://www.biospace.com/article/ai...x-genentech-execs-look-to-transform-r-and-d-/